NHS Health Checks: an observational study of equity and outcomes 2009-2017
- PMID: 33587723
- PMCID: PMC8216267
- DOI: 10.3399/BJGP.2020.1021
NHS Health Checks: an observational study of equity and outcomes 2009-2017
Abstract
Background: The NHS Health Check cardiovascular prevention programme is now 10 years old.
Aim: To describe NHS Heath Check attendance, new diagnoses, and treatment in relation to equity indicators.
Design and setting: A nationally representative database derived from 1500 general practices from 2009-2017.
Method: The authors compared NHS Health Check attendance and new diagnoses and treatments by age, sex, ethnic group, and deprivation.
Results: In 2013-2017, 590 218 (16.9%) eligible people aged 40-74 years attended an NHS Health Check and 2 902 598 (83.1%) did not attend. South Asian ethnic groups were most likely to attend compared to others, and females more than males. New diagnoses were more likely in attendees than non-attendees: hypertension 25/1000 in attendees versus 9/1000 in non-attendees; type 2 diabetes 8/1000 versus 3/1000; and chronic kidney disease (CKD) 7/1000 versus 4/1000. In people aged ≥65 years, atrial fibrillation was newly diagnosed in 5/1000 attendees and 3/1000 non-attendees, and for dementia 2/1000 versus 1/1000, respectively. Type 2 diabetes, hypertension, and CKD were more likely in more deprived groups, and in South Asian, Black African, and Black Caribbean ethnic groups. Attendees were more likely to be prescribed statins (26/1000) than non-attendees (8/1000), and antihypertensive medicines (25/1000 versus 13/1000 non-attendees). However, of the 117 963 people with ≥10% CVD risk who were eligible for statins, only 9785 (8.3%) were prescribed them.
Conclusion: Uptake of NHS Health Checks remains low. Attendees were more likely than non-attendees to be diagnosed with type 2 diabetes, hypertension, and CKD, and to receive treatment with statins and antihypertensives. Most attendees received neither treatment nor referral. Of those eligible for statins, <10% were treated. Policy reviews should consider a targeted approach prioritising those at highest CVD risk for face-to-face contact and consider other options for those at lower CVD risk.
Keywords: NHS Health Check; antihypertensives; cardiovascular disease; statins.
© The Authors.
Figures
Comment in
-
Interpretation of ethnicity-specific data: increased risk versus increased utilisation.Br J Gen Pract. 2021 Oct 28;71(712):495. doi: 10.3399/bjgp21X717461. Print 2021 Nov. Br J Gen Pract. 2021. PMID: 34711575 Free PMC article. No abstract available.
References
-
- Marmot M, Allen J, Boyce T, et al. Health equity in England: The Marmot Review 10 years on. 2020. https://www.health.org.uk/publications/reports/the-marmot-review-10-year... (accessed 3 Jun 2021). - PubMed
-
- British Heart Foundation Death rates — over time. 2020 https://www.bhf.org.uk/what-we-do/our-research/heart-and-circulatory-dis... (accessed 3 Jun 2021).
-
- Public Health England NHS Health Check best practice guidance For commissioners and providers. 2020 https://www.healthcheck.nhs.uk/commissioners-and-providers/national-guid... (accessed 3 Jun 2021).
-
- Capewell S, McCartney M, Holland W. NHS Health Checks — a naked emperor? J Public Health. 2015;37(2):187–192. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical